vs
ORTHOPEDIATRICS CORP（KIDS）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
ORTHOPEDIATRICS CORP的季度营收约是STEM, INC.的1.3倍（$61.6M vs $47.1M），ORTHOPEDIATRICS CORP净利率更高（-16.4% vs -33.9%，领先17.5%），ORTHOPEDIATRICS CORP同比增速更快（17.0% vs -15.6%），过去两年STEM, INC.的营收复合增速更高（36.1% vs 17.4%）
OrthoPediatrics是一家美国生物科技企业，总部位于印第安纳州华沙，专注于设计、研发、生产并分销用于儿科诊疗的骨科植入物与手术器械。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
KIDS vs STEM — 直观对比
营收规模更大
KIDS
是对方的1.3倍
$47.1M
营收增速更快
KIDS
高出32.5%
-15.6%
净利率更高
KIDS
高出17.5%
-33.9%
两年增速更快
STEM
近两年复合增速
17.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.6M | $47.1M |
| 净利润 | $-10.1M | $-16.0M |
| 毛利率 | 73.2% | 48.9% |
| 营业利润率 | -13.3% | -17.7% |
| 净利率 | -16.4% | -33.9% |
| 营收同比 | 17.0% | -15.6% |
| 净利润同比 | 37.1% | 68.8% |
| 每股收益（稀释后） | $-0.43 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KIDSSTEM
| Q4 25 | $61.6M | $47.1M | ||
| Q3 25 | $61.3M | $38.2M | ||
| Q2 25 | $61.1M | $38.4M | ||
| Q1 25 | $52.4M | $32.5M | ||
| Q4 24 | $52.7M | $55.8M | ||
| Q3 24 | $54.6M | $29.3M | ||
| Q2 24 | $52.8M | $34.0M | ||
| Q1 24 | $44.7M | $25.5M |
净利润KIDSSTEM
| Q4 25 | $-10.1M | $-16.0M | ||
| Q3 25 | $-11.8M | $-23.8M | ||
| Q2 25 | $-7.1M | $202.5M | ||
| Q1 25 | $-10.7M | $-25.0M | ||
| Q4 24 | $-16.1M | $-51.1M | ||
| Q3 24 | $-7.9M | $-148.3M | ||
| Q2 24 | $-6.0M | $-582.3M | ||
| Q1 24 | $-7.8M | $-72.3M |
毛利率KIDSSTEM
| Q4 25 | 73.2% | 48.9% | ||
| Q3 25 | 73.9% | 35.5% | ||
| Q2 25 | 72.1% | 33.4% | ||
| Q1 25 | 73.0% | 32.4% | ||
| Q4 24 | 67.5% | -4.4% | ||
| Q3 24 | 73.4% | 21.2% | ||
| Q2 24 | 77.3% | 27.6% | ||
| Q1 24 | 72.0% | -95.0% |
营业利润率KIDSSTEM
| Q4 25 | -13.3% | -17.7% | ||
| Q3 25 | -15.4% | -33.6% | ||
| Q2 25 | -17.4% | -34.8% | ||
| Q1 25 | -21.0% | -65.0% | ||
| Q4 24 | -26.7% | -84.4% | ||
| Q3 24 | -10.2% | -493.2% | ||
| Q2 24 | -10.7% | -1705.5% | ||
| Q1 24 | -21.8% | -267.0% |
净利率KIDSSTEM
| Q4 25 | -16.4% | -33.9% | ||
| Q3 25 | -19.2% | -62.2% | ||
| Q2 25 | -11.6% | 527.8% | ||
| Q1 25 | -20.3% | -76.9% | ||
| Q4 24 | -30.5% | -91.6% | ||
| Q3 24 | -14.5% | -506.3% | ||
| Q2 24 | -11.4% | -1712.6% | ||
| Q1 24 | -17.5% | -283.9% |
每股收益（稀释后）KIDSSTEM
| Q4 25 | $-0.43 | $-4.40 | ||
| Q3 25 | $-0.50 | $-2.84 | ||
| Q2 25 | $-0.30 | $-1.79 | ||
| Q1 25 | $-0.46 | $-0.15 | ||
| Q4 24 | $-0.70 | $-15.29 | ||
| Q3 24 | $-0.34 | $-18.24 | ||
| Q2 24 | $-0.26 | $-71.81 | ||
| Q1 24 | $-0.34 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.9M | $48.9M |
| 总债务越低越好 | $106.0M | — |
| 股东权益账面价值 | $346.6M | $-249.4M |
| 总资产 | $508.6M | $308.9M |
| 负债/权益比越低杠杆越低 | 0.31× | — |
8季度趋势，按日历期对齐
现金及短期投资KIDSSTEM
| Q4 25 | $60.9M | $48.9M | ||
| Q3 25 | $57.7M | $43.1M | ||
| Q2 25 | $70.1M | $40.8M | ||
| Q1 25 | $58.8M | $58.6M | ||
| Q4 24 | $68.8M | $56.3M | ||
| Q3 24 | $76.1M | $75.4M | ||
| Q2 24 | $28.9M | $89.6M | ||
| Q1 24 | $47.7M | $112.8M |
总债务KIDSSTEM
| Q4 25 | $106.0M | — | ||
| Q3 25 | $105.3M | — | ||
| Q2 25 | $102.7M | — | ||
| Q1 25 | $77.4M | — | ||
| Q4 24 | $77.5M | — | ||
| Q3 24 | $76.9M | — | ||
| Q2 24 | $11.2M | — | ||
| Q1 24 | $11.3M | — |
股东权益KIDSSTEM
| Q4 25 | $346.6M | $-249.4M | ||
| Q3 25 | $349.3M | $-235.7M | ||
| Q2 25 | $355.5M | $-214.1M | ||
| Q1 25 | $347.1M | $-417.5M | ||
| Q4 24 | $354.6M | $-398.4M | ||
| Q3 24 | $370.9M | $-344.1M | ||
| Q2 24 | $371.3M | $-203.2M | ||
| Q1 24 | $370.6M | $371.6M |
总资产KIDSSTEM
| Q4 25 | $508.6M | $308.9M | ||
| Q3 25 | $493.5M | $362.6M | ||
| Q2 25 | $503.6M | $379.2M | ||
| Q1 25 | $470.3M | $405.1M | ||
| Q4 24 | $473.2M | $437.4M | ||
| Q3 24 | $489.3M | $537.8M | ||
| Q2 24 | $430.8M | $691.5M | ||
| Q1 24 | $437.2M | $1.3B |
负债/权益比KIDSSTEM
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.03× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.3M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $9.7M | — |
| 自由现金流率自由现金流/营收 | 15.8% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-16.0M | — |
8季度趋势，按日历期对齐
经营现金流KIDSSTEM
| Q4 25 | $10.3M | $8.2M | ||
| Q3 25 | $-581.0K | $11.4M | ||
| Q2 25 | $-10.5M | $-21.3M | ||
| Q1 25 | $-4.2M | $8.5M | ||
| Q4 24 | $-4.0M | $-14.7M | ||
| Q3 24 | $-10.3M | $-9.4M | ||
| Q2 24 | $-6.1M | $-11.9M | ||
| Q1 24 | $-6.7M | $-621.0K |
自由现金流KIDSSTEM
| Q4 25 | $9.7M | — | ||
| Q3 25 | $-3.4M | — | ||
| Q2 25 | $-13.9M | — | ||
| Q1 25 | $-8.4M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-11.7M | — | ||
| Q2 24 | $-12.8M | — | ||
| Q1 24 | $-13.2M | — |
自由现金流率KIDSSTEM
| Q4 25 | 15.8% | — | ||
| Q3 25 | -5.6% | — | ||
| Q2 25 | -22.8% | — | ||
| Q1 25 | -16.0% | — | ||
| Q4 24 | -8.1% | — | ||
| Q3 24 | -21.4% | — | ||
| Q2 24 | -24.2% | — | ||
| Q1 24 | -29.4% | — |
资本支出强度KIDSSTEM
| Q4 25 | 1.0% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 12.7% | — | ||
| Q1 24 | 14.5% | — |
现金转化率KIDSSTEM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
